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 ABSTRACT
Over the last decades extended medical knowledge 
has been an important health care benefit in terms 
of disease prevention and management. However, 
probably with no exception, most pharmaceutical 
products are not devoid of adverse consequences.
Immunomodulators are commonly considered a 
“benign” drug whose advantages bypass conse-
quences. The immunomodulator AM3 (Immunoferon®) 
is a clinically used, orally administered compound 
whose active principle is stabilised in an inorganic 
matrix of calcium.
We report the misuse of AM3 in three members 
of a family; father and two children. The drug was 
prescribed to the father who subsequently adminis-
tered it to the children without seeking medical 
advice. Two months later, all subjects developed 
abdominal and/or flank colicky pain. Hypercalciuria 
was diagnosed in the children with different degrees 
of severity. It is likely that the calcium content of 
the inorganic matrix played an important role in the 
onset of symptoms.
No adverse side effects related to the inorganic 
matrix of calcium of immunoferon® have been docu-
mented so far. This family case report calls attention 
to the risks of self -medication in a susceptible family.
Paediatric patients are vulnerable as they rely on 
adults for the supply of medications. Concerning the 
use of drugs in family, especially nonprescription 
drugs, the quality of health care provided to the chil-




Self -medication (SM) can be seen as a modern 
style of self-care which is increasing in developed 
countries. Some social factors may be considered 
important causes behind this rise of SM, such as the 
decrease in prescription coverage by National Health/
social security services, the availability of over -the-
counter health products and the increasing presence 
of pharmaceutical products in the media1,2.
Immunoferon (AM3) is an orally effective immu-
nomodulator which influences regulatory and effec-
tors functions of the immune system and whose 
molecular mechanism of action is mostly unknown. 
The active principle is a glycoconjugate of natural 
origin composed of glucomannan polysaccharide 
from Candida utilis and a storage protein from non-
germinated seeds of Ricinus communis3. Its use in 
adults and children with chronic lung disease and 
asthma is documented4,5.
Immunoferon® is available in 500mg capsules 
containing glycopeptides/protein stabilised in an 
The risks of self -medication: 
case report of familial misuse 
of AM3 (Immunoferon®)
Marta Oliveira, Rute Neves, Margarida Abranches
Paediatric Nephrology Unit, Department of Paediatrics, Hospital Dona Estefânia. Lisboa, Portugal.
Received for publication: 13/05/2010
Accepted in revised form: 20/08/2010
CASE REPORT
Port J Nephrol Hypert 2010; 24(4): 301-303
Advance Access publication 17 September 2010
Nefro - 24-4 - MIOLO OK.indd   Sec1:301 15-11-2010   10:17:18
302    Port J Nephrol Hypert 2010; 24(4): 301-303
CMYKP
Marta Oliveira, Rute Neves, Margarida Abranches
inorganic matrix of calcium phosphosulfate (10 mg 
AM3 and 490 mg calcium phosphosulfate).
 CASE REPORT
Female, 11 years old, complained of fever, abdom-
inal pain and diarrhoea. Two days later she was 
admitted to the emergency services with an abdom-
inal colicky pain irradiating to the right flank. Urine 
sediment and urine culture were normal. An abdom-
inal ultrasonography showed an enlarged right kid-
ney with diffuse hyperecogenicity of the cortex and 
dilatation of the renal pelvis (28mm) and of the 
homolateral ureter (8mm). Contrast -enhanced com-
puted tomography scanning revealed right uretero-
hydronephrosis with diminished uptake, concentra-
tion and excretion of the ionising contrast and a 
normal left kidney. Cystoscopy was performed and 
revealed obstruction at the third distal portion of the 
right ureter. Reimplantation of the right ureter and 
insertion of a stent was successfully performed. A 
sandy -like material causing the obstruction was 
removed and not sent for analysis. During recovery, 
serum creatinine and urea were normal (Screatinine 
0.9 mg/dl, Surea 40 mg/dl), urine biochemistry only 
revealed hypercalciuria (CaU/CrU=0.3); other serum 
biochemistry parameters including serum calcium 
were normal (SCa 9.3 mg/dl). Hypercalciuria normal-
ised spontaneously. She was followed up for four 
consecutive years: blood and urine biochemistry were 
always normal, serial renal ultrasonograms showed 
no lithiasis and dynamic renal scintigraphy showed 
normal renal function with no significant asymmetries 
and without dilatation of the right urinary tract.
One week after her hospital admission, while 
recovering from the urological surgery, her brother, 
aged three, was also admitted to the emergency 
services with an abdominal colicky pain. Analgesic 
and intravenous fluid therapy kept the pain under 
control. Abdominal and renal ultrasonography were 
normal. Urine sediment, urine culture and blood bio-
chemistry, including serum calcium, showed no 
alterations. Chemical analysis of the urine consist-
ently revealed hypercalciuria (UCa 6 -10mg/kg/day), 
and other urine chemical parameters were normal. 
A low sodium diet and high fluid intake were not 
enough to manage the hypercalciuria and hydrochlo-
rothiazide was successfully introduced. Serial renal 
ultrasonograms never revealed lithiasis. Currently 
aged 11, he is still under surveillance.
The family was questioned as to dietary habits 
and medications. A three-day diet report was 
requested, and its calcium intake was evaluated and 
considered normal. No vitamins or calcium supple-
ments were being given to the children. However, 
their father mentioned taking Immunoferon® and 
self-administering it to his children. He admitted that 
Immunoferon® had been prescribed for prevention 
of his recurrent upper respiratory infections nine 
months before his children’s hospital admissions. 
He took the medication as prescribed, 500mg three 
times a day, for three consecutive months, and used 
the same drug as self -medication, a second time, 
two months prior to the hospitalisations. This last 
time, he decided to administer it to both his children 
without seeking medical advice. Moreover, he had 
two episodes of colicky flank pain which had resolved 
spontaneously. His last episode occurred two weeks 
prior to his children’s hospital admissions. When 
questioned, he refused to test his urine and blood 
for calcium content.
 DISCUSSION
Over the past three decades, there has been a 
tremendous rise in available treatments as a result of 
extended medical knowledge. The prevalence of non-
prescription drug use is rising in the world, as is the 
potential for therapeutic misuse. All prescription and 
nonprescription drugs are powerful chemical entities 
with well-defined pharmacology and toxicology6,7.
Various definitions of SM are available in the lit-
erature as well as various prevalence studies of SM 
with different results from different countries. In Por-
tugal, two prevalence studies were carried out in urban 
and rural populations with results of 26.2% and 21.5% 
respectively8,9. In Spain, prevalence of SM in a sample 
representative of the Spanish population2 was 12.7%. 
One must take into account that prevalence of SM in 
different countries is difficult to compare because 
there is no standard measurement of SM.
In this familial case report, there seemed to be a 
cause -effect relationship between the administration 
of a self -medicated drug, Immunoferon®, and the 
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occurrence of colicky pain in three family members. 
In this case, calcium content of the inorganic matrix 
of Immunoferon® probably played an important role. 
Although the package leaflet of Immunoferon® calls 
attention to the risks of administration in cases of 
hypercalcaemia, there is no reference to hypercalciuria. 
Furthermore, a previous undiagnosed urinary tract 
anomaly in the daughter could possibly justify the 
severity of the unilateral urologic obstruction in need 
of surgical repair. Regarding her brother, a colicky 
pain episode probably disclosed a previous undiag-
nosed hypercalciuric state. Their father’s report of two 
colicky pain episodes, both concomitant with admin-
istration of Immunoferon®, were not fully explained 
since laboratory tests were not performed.
Calcium metabolism depends on the calcium con-
tent of the diet, the absorption from the gut and 
the tubular reabsorption of the kidney. A diminished 
renal tubular reabsorption increases the excretion of 
calcium and induces a hypercalciuric state. In cases 
of hypercalciuria induced by diminished tubular rea-
bsorption of calcium, any overload of calcium, die-
tary or iatrogenic, will increase the excretion of cal-
cium and enhance a hypercalciuric state. Thiazide 
diuretics reduce renal excretion of calcium by increas-
ing calcium tubular reabsorption as in our case. The 
most common cause of hypercalciuria is idiopathic 
but it can be familial, hence the importance of know-
ing the calcium metabolism of all the family members 
with colicky symptoms.
As shown by this family case report, the use of 
nonprescription drugs calls for the health literacy 
of patients and caregivers10. There are population 
groups with special needs, with paediatric patients 
among the most vulnerable due to age consider-
ations and dependency on adults to supply the 
medication.
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